Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

Political pressure and persistently high interest rates have some wondering if the industry’s model is broken.

Learn more about whether Alvotech or Recursion Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

Peer Danaher also beat first-quarter profit estimate on better-than-expected demand for its respiratory testing kits. Thermo ...

Deep tech innovations, rooted in scientific research and engineering, are quietly revolutionizing North Carolina's economy.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Roche’s drug production operations are set to benefit from the company’s updated U.S. strategy, including with “expanded and ...

It is important to delve into an ETF's holdings before investing despite ... SPDR S&P Biotech ETF (XBI) tracks S&P Biotechnology Select Industry Index and the iShares Biotechnology ETF (IBB ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

On the buying side, ARK’s ARKG ETF acquired 2161 shares of biopharmaceutical giant Amgen Inc (NASDAQ: AMGN ), with a total investment of around $599,223. This purchase signals a growing interest in ...